Source link : https://www.newshealth.biz/health-news/many-patients-with-advanced-mcc-not-receiving-immunotherapy/
PHOENIX — Immunotherapy has revolutionized outcomes for patients with metastatic Merkel cell carcinoma (MCC). However, findings from a new study suggest that many patients who are eligible for immunotherapy are not receiving this treatment, despite guideline recommendations, and survival outcomes are better at high-volume centers. The study has important implications, commented study author Shayan Cheraghlou, […]
Author : News Health
Publish date : 2024-05-06 04:01:48
Copyright for syndicated content belongs to the linked Source.